This message got through OK. Go into your Sent Items and select a message
that was truncated and View:Source. Is it truncated there? If there isn't a
privacy issue, paste the source of the message into a reply to this post.
Also, try sending with a different SMTP server if you have access to one. It
might be a server issue.
Hi again - and thanks for your concern!
I know that some mail goes through without problems (usually the first ones
I send in the day). In my sent mailbox everything looks ok. It even looks
like I got the attachments sent. However, since this started I always CC
myself to see if the mails gets through ok. Anyway, I am attaching the first
part of the source of a mail I sent (not the attachment part) and after that
I supply the CC return. Some things suggest that it is not just a server
issue. Again, quite often when I do a reply I do not get the whole message
with (even though this is my default setting). If I do the same a couple of
times it eventually gets the whole message. Again I believe this started
after patching Office from 10.1.3.
Sent message:
User-Agent: Microsoft-Entourage/10.1.4.030702.0
Date: Tue, 23 Sep 2003 11:51:31 +0200
Subject: Re: antibacterial&haemolytic activities of betaoligoArgs
From: "Per I. Arvidsson" <
[email protected]>
To: Kenji Namoto <
[email protected]>
Message-ID: <BB95E447.295F%
[email protected]>
In-Reply-To: <000801c381ae$949bb1b0$2be48481@KENJI>
Mime-version: 1.0
Content-type: multipart/mixed; boundary="B_3147242470_115051"
This message is in MIME format. Since your mail reader does not understand
this format, some or all of this message may not be legible.
--B_3147242470_115051
Content-type: multipart/alternative; boundary="B_3147242470_134871"
--B_3147242470_134871
Content-type: text/plain; charset="ISO-8859-1"
Content-transfer-encoding: quoted-printable
Hi Kenji,
Good to hear that you still do work on the poly-Arg molecules. It is a
fascinating topic. I was just doing a literature search on this topic (not
b-peptides though) when your mail arrived =AD a strange coincidence!
I have paper copies of all the reports by Dr. Weiss (Hemolysis) and Dr.
Ryder (Antibacterial). These reports I got by normal mail from Prof.
Seebach. I have two electronic versions on my computer which I am attaching=
..
None of these contains the data of the poly-Arg molecule. These data are
reported in the reported dated 15-Jan-2003 (hemolysis) and in an e-mail fro=
m
Dr. Ryder to Prof. Seebach dated 23-Aug-2002 (antibact).
All Novartis experiments seem to be performed in the same way, so hopefully
you will find one electronic file for each type of investigation. If not,
let me know and I will fax you my paper copies.
If you find electronic versions with the experimental data, please also
forward these to me since I need them for the experimental section of the
=B3full=B2 antibacterial paper we are preparing.
Good luck!
Per
/Please give my best greeting to Prof. Seebach and the others I still might
know in the group!
Dear Prof. Dr. Arvidsson,
=20
My name is Kenji Namoto, a postdoc with the group of Prof. Dr. Seebach at= ETH.
We are now in preparation of a manuscript on our recent chemical and
biological investigations about beta-oligoarginines for the upcoming firs= t
issue of a new journal Chemistry&Biodiversity, and hence decided to inclu= de
the results from the antibacterial and haemolytic assays on
beta-oligoarginines. Your recent table summarizing the assay results is
already at our hand, but we would be very grateful if you have further
information to forward to us regarding the assay, such as specific assay
conditions and references (we are also trying to contact Dr. Weiss at
Novartis). Thank you in advance for your kind attention and time to hel= p us.
=20
Yours sincerely,
Kenji Namoto
The Seebach Group
Laboratorium fuer Organische Chemie
ETH-Hoenggerberg
=20
=20
=20
=20
--=20
Dr. Per I. Arvidsson
Assistant Professor of Chemistry
Department of Organic Chemistry
Institute of Chemistry
Husargatan 3 (Visiting)
Box 599, BMC B7:412b (Postal)
SE-751 24 Uppsala, Sweden
phone: +46-(0)18-471 3787
fax: +46-(0)18-4713818
e-mail:
[email protected]
http://www.org.kemi.uu.se/Research/Pia/Piahem.htm
*****************************
Private:
Gammelekev=E4gen 73 =20
SE-74082 =D6rsundsbro
Sweden
phone: +46-(0)171-460975
mobile:+46-70-373 1483
--B_3147242470_134871
Content-type: text/html; charset="ISO-8859-1"
Content-transfer-encoding: quoted-printable
<HTML>
<HEAD>
<TITLE>Re: antibacterial&haemolytic activities of betaoligoArgs</TITLE>
</HEAD>
<BODY>
<FONT FACE=3D"Verdana"><SPAN STYLE=3D'font-size:12.0px'>Hi Kenji,<BR>
<BR>
Good to hear that you still do work on the poly-Arg molecules. It is a fasc=
inating topic. I was just doing a literature search on this topic (not
b-pep=
tides though) when your mail arrived – a strange coincidence! <BR>
<BR>
I have paper copies of all the reports by Dr. Weiss (Hemolysis) and Dr. Ryd=
er (Antibacterial). These reports I got by normal mail from Prof. Seebach.
I=
have two electronic versions on my computer which I am attaching. None of
t=
hese contains the data of the poly-Arg molecule. These data are reported in
=
the reported dated 15-Jan-2003 (hemolysis) and in an e-mail from Dr. Ryder
t=
o Prof. Seebach dated 23-Aug-2002 (antibact).<BR>
<BR>
All Novartis experiments seem to be performed in the same way, so hopefully=
you will find one electronic file for each type of investigation. If not,
l=
et me know and I will fax you my paper copies.<BR>
<BR>
If you find electronic versions with the experimental data, please also for=
ward these to me since I need them for the experimental section of the
̶=
0;full” antibacterial paper we are preparing.<BR>
<BR>
Good luck!<BR>
<BR>
Per<BR>
/Please give my best greeting to Prof. Seebach and the others I still might=
know in the group!<BR>
<BR>
<BR>
On 03-09-23 10.42, "Kenji Namoto" <
[email protected].=
ch> wrote:<BR>
<BR>
Dear Prof. Dr. Arvidsson,<BR>
</FONT><FONT FACE=3D"Verdana"> <BR>
</FONT><FONT FACE=3D"Arial">My name is Kenji Namoto, a postdoc with the
group=
of Prof. Dr. Seebach at ETH. We are now in preparation of a
manuscrip=
t on our recent chemical and biological investigations about
beta-oligoargin=
ines for the upcoming first issue of a new journal
Chemistry&Biodiversit=
y, and hence decided to include the results from the antibacterial and
haemo=
lytic assays on beta-oligoarginines. Your recent table
summarizi=
ng the assay results is already at our hand, but we would be very grateful
i=
f you have further information to forward to us regarding the assay, such
as=
specific assay conditions and references (we are also trying to contact
Dr.=
Weiss at Novartis). Thank you in advance for your kind
attentio=
n and time to help us. <BR>
</FONT><FONT FACE=3D"Verdana"> <BR>
</FONT><FONT FACE=3D"Arial">Yours sincerely,<BR>
Kenji Namoto<BR>
The Seebach Group<BR>
Laboratorium fuer Organische Chemie<BR>
ETH-Hoenggerberg<BR>
</FONT><FONT FACE=3D"Verdana"> <BR>
<BR>
<BR>
<BR>
</FONT></SPAN></BLOCKQUOTE><SPAN STYLE=3D'font-size:12.0px'><FONT
FACE=3D"Verda=
na"><BR>
<BR>
</FONT><FONT FACE=3D"New York">-- <BR>
Dr. Per I. Arvidsson<BR>
Assistant Professor of Chemistry<BR>
Department of Organic Chemistry<BR>
Institute of Chemistry<BR>
Husargatan 3 (Visiting)<BR>
Box 599, BMC B7:412b (Postal)<BR>
SE-751 24 Uppsala, Sweden<BR>
phone: +46-(0)18-471 3787<BR>
fax: +46-(0)18-4713818<BR>
e-mail:
[email protected] <BR>
<a
href=3D"
http://www.org.kemi.uu.se/Research/Pia/Piahem.htm">
http://www.org.=
kemi.uu.se/Research/Pia/Piahem.htm</a><BR>
*****************************<BR>
Private:<BR>
Gammelekevägen 73 <BR>
SE-74082 Örsundsbro <BR>
Sweden<BR>
phone: +46-(0)171-460975<BR>
mobile:+46-70-373 1483<BR>
</FONT><FONT FACE=3D"Verdana"><BR>
</FONT></SPAN>
</BODY>
</HTML>
--B_3147242470_134871--
--B_3147242470_115051
Content-type: application/msword; name="M0102 Test Report Jan-02.doc";
x-mac-creator="4D535744";
x-mac-type="5738424E"
Content-disposition: attachment
Content-transfer-encoding: base64
Received CC:
Received: from elanus.its.uu.se(127.0.0.1) by elanus.its.uu.se via
virus-scan
id s22083; Tue, 23 Sep 03 11:49:38 +0200
Received: from [130.238.236.143] (kemi143.kemi.uu.se [130.238.236.143])
by elanus.its.uu.se (Postfix) with ESMTP
id 781D84DA9; Tue, 23 Sep 2003 11:46:31 +0200 (DFT)
User-Agent: Microsoft-Entourage/10.1.4.030702.0
Date: Tue, 23 Sep 2003 11:51:31 +0200
Subject: Re: antibacterial&haemolytic activities of betaoligoArgs
From: "Per I. Arvidsson" <
[email protected]>
To: Kenji Namoto <
[email protected]>
Message-ID: <BB95E447.295F%
[email protected]>
In-Reply-To: <000801c381ae$949bb1b0$2be48481@KENJI>
Mime-version: 1.0
Content-type: multipart/mixed; boundary="B_3147162695_583357"
This message is in MIME format. Since your mail reader does not understand
this format, some or all of this message may not be legible.
--B_3147162695_583357
Content-type: multipart/alternative; boundary="B_3147162695_602052"
--B_3147162695_602052
Content-type: text/plain; charset="ISO-8859-1"
Content-transfer-encoding: quoted-printable
Hi Kenji,
Good to hear that you still do work on the poly-Arg molecules. It is a
fascinating topic. I was just doing a literature search on this topic (not
b-peptides though) when your mail arrived =AD a strange coincidence!
I have paper copies of all the reports by Dr. Weiss (Hemolysis) and Dr.
Ryder (Antibacterial). These reports I got by normal mail from Prof.
Seebach. I have two electronic versions on my computer which I am attaching=
